Natural Course of Neonatal Progeroid Syndrome  by Hou, Jia-Woei
©2009 Taiwan Pediatric Association
ORIGINAL ARTICLE
Pediatr Neonatol 2009;50(3):102−109
Corresponding author. Department of Pediatrics, Cathay General Hospital, 280, Section 4, Jen-Ai Road, Taipei 106, Taiwan.
E-mail: houjw4876@gmail.com
Background: Several progeroid disorders presenting a specific “old-man” appear-
ance since birth or childhood have been described. Here, five patients with a 
history of severe intrauterine and postnatal growth retardation and pseudohydro-
cephaloid cranium noted after birth that were suggestive of neonatal progeroid 
syndrome (NPS) or Wiedemann-Rautenstrauch syndrome are reported. We discuss 
the natural course of the syndrome.
Methods: A series of anthropometric measurements, imaging, dual energy X-ray 
absorptiometry, and endocrine investigations to assess metabolic complications 
such as hyperinsulinemia and dyslipidemia were performed on these five patients 
who were followed for 1−7 years. Screening of inborn errors, karyotyping, chromo-
somal breakage rates and DNA mutational studies with direct sequencing of LMNA, 
ERCC8 and ZMPSTE24 genes were also performed.
Results: Generalized lipodystrophy was noted in all patients except for regions 
such as the cheeks, hands and feet. All cases had failure to thrive, microcephaly, 
ear dysplasia, laryngomalacia, hearing impairment, gastro-esophageal reflux dis-
ease, constipation, abnormal dentition, dermatitis/acrodermatitis enteropathica, 
hyperpigmentation of the skin, very low insulin-like growth factor I levels with 
delayed bone age, relative hypolipidemia, initial camptodactyly/joint contracture, 
progressive kyphoscoliosis, osteoporosis with loose joints, ventriculomegaly, and 
generalized organic aciduria. Other findings included inguinal hernia, hypothyroidism 
or persistent hyperthyrotropinemia, cryptorchidism, hip dysplasia, growth hormone 
deficiency, cloudy cornea with congenital glaucoma, neonatal teeth, cardiac defects, 
basal ganglia calcification and seizure disorder. These patients with NPS did not 
show hyperinsulinemia or dyslipidemia. Their karyotypes were all normal, while 
the chromosomal breakage test showed markedly increased breakage rates in four 
patients. LMNA, ERCC8, or ZMPSTE24 gene mutations could not account for the 
disorders in these patients. Four patients died after sepsis or aspiration pneumonia 
at the age of 1.1, 4, 6.2 and 7.5 years.
Conclusion: Increased chromosomal breakage and the presence of basal ganglia 
calcification after early childhood suggest that DNA repair defects are involved in 
the pathogenesis of this disorder. This rare disorder represents a complex of symp-
toms with unknown cause and pathogenesis, and more than one disease may 
account for the clinical variability of NPS.
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1. Introduction
Certain clinical entities presenting a specific “old-
man” appearance since birth or childhood have 
been described as progeroid or progeria disorders.1−4 
Among them, a syndrome with manifestations of 
pre- and postnatal growth deficiency, pseudohy-
drocephalus, a small and already senile-appearing 
face since birth, often neonatal teeth, and exten-
sive deficiency of adipose tissue was described as 
neonatal progeroid syndrome (NPS), also called 
Wiedemann-Rautenstrauch syndrome (OMIM no. 
264090).1,2,5−9 Since the first Taiwanese case of 
NPS was reported in 1995,10 a further four infants 
with similar features have subsequently been found. 
They all presented with an aged and dysmorphic 
face, decreased subcutaneous fat tissue, with se-
verely delayed growth and psychomotor retarda-
tion. Some lipodystrophic features of NPS overlap 
with those of several other progeroid conditions in 
childhood, such as Cockayne syndrome (CS, OMIM 
no. 216400, 759826),3 Hutchinson-Gilford syndrome 
(HGS, OMIM no.176670), caused by LMNA gene 
mutations,4 and Hallerman-Streiff syndrome (OMIM 
no. 234100).11 Long-term observations of the natu-
ral evolution of NPS are limited because of the 
relatively short survival of most patients.2,8 The 
phenotype may evolve as the patient gets older.2,9,12 
Until now, the etiological and pathological aspects 
of NPS have remained heterogeneous.13−15 We fol-
lowed up five patients with NPS in terms of growth 
and development, biochemical and metabolic/
endocrine profiles, chromosome studies and break-
age study, imaging examinations, and direct se-
quencing of the LMNA (encoding nuclear lamin 
A/C), ERCC8, and ZMPSTE24 (zinc metalloprotease) 
genes,3,4,14 to explore and elucidate the pathogen-
esis and natural course of this disease.
2. Subjects and Methods
2.1. Physical evaluation
The major diagnostic criteria of NPS are as follows: 
an old-looking face with hydrocephalic appearance, 
prominent scalp veins and sparse scalp hair, open 
wide anterior fontanel (AF), often neonatal teeth, 
abnormal tooth status, feeding difficulties with a 
failure to thrive, absence of subcutaneous fat (lipo-
atrophy) around the buttocks, anogenital area and 
on the flanks, relatively large hands and feet with 
long fingers and toes, muscle hypotonia, and psy-
chomotor retardation.1,2,5−9 A total of five infants 
with features of NPS were encountered with a 
male-to-female ratio of 3:2 (Table). Family history 
was generally unremarkable, except for a possible 
consanguinity from two second cousins as the par-
ents of patient 2. The anthropometric parameters 
of these patients were investigated and followed 
for 1−7.5 years.
2.2. Laboratory evaluation
We investigated the following: hematocrit, albu-
min/globulin, liver/kidney function, lipid profile, 
trace elements such as zinc, tandem mass study, 
and urine organic profile by gas chromatography/
mass spectrometry. Endocrine variables included 
thyroid function, insulin-like growth factor-I (IGF-I), 
glucose, insulin resistance, growth hormone (GH) 
provocative tests by insulin/clonidine and bone age. 
Insulin resistance was calculated using the homeos-
tasis model assessment score. Further examinations 
including electroencephalography (EEG), brain-stem 
auditory evoked response (BAER), bone mineral den-
sitometry (BMD, Norland) over the lumbar spine 
(L1−L4) via dual-energy X-ray absorptiometry and 
Z-scores for age-matched children, and imaging 
studies such as brain computed tomography (CT) 
and/or magnetic resonance imaging (MRI) were 
also performed. Genetic studies were as follows: 
skin fibroblast culture, chromosome study (high-
resolution banding of the peripheral blood lympho-
cyte, skin fibroblast, and breakage tests),11 and 
molecular studies of the genes encoding lamin A/C 
proteins (LMNA, locus: 1q21-22; 24 kb, 12 exons), 
excision repair cross-complementing 8 (ERCC8 or 
CSA, locus: 5q11.2; 80 kb, 12 exons) and a zinc met-
alloprotease essential for the post-translational 
cleavage of the Lamin A precursors and the pro-
duction of mature of Lamin A (ZMPSTE24, locus: 
1p34; 36.1 kb, 10 exons).
2.3. Patient 1
A small for gestational age (SGA) male infant (Figure 
1), the first child of healthy young parents, was born 
spontaneously via vagina at gestational age (GA) 
of 40 weeks, weighing 1570 g, length 37.5 cm, and 
head circumference (HC) 30 cm, after a full-term 
pregnancy complicated by intrauterine growth re-
tardation (IUGR), polyhydramnios and elevated α-
fetoprotein (AFP) levels (in both maternal blood and 
amniotic fluid). Tube feeding had been maintained 
since the neonatal stage because of hypotonia, 
laryngomalacia and severe gastroesophageal reflux 
(GER). Neurosensory hearing impairment was de-
tected by BAER examination. The patient suffered 
from an inguinal hernia, recurrent respiratory infec-
tions associated with dermatitis, low levels of free 
thyroxine (T4, 9 pmol/L, normal range: 12−33 pmol/L), 
triiodothyronine (T3, 0.99 nmol/L, 1.54−4.00 nmol/
L), zinc and IgA, along with hyperthyrotropinemia 
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Table Clinical features and laboratory findings of five patients with NPS
Features/patient  1 2 3 4 5
Sex Male Female Male Male Female
Consanguinity −  +  − − −
IUGR  +  Borderline  +   +   + 
Gestation (wk)  40 36 37 39 36
Birth weight (g) (percentile) 1570 (< 3rd) 2350 (3rd) 1750 (< 3rd) 2100 (< 3rd) 2150 (< 3rd)
Birth length (cm) (percentile) 37.5 (< 3rd) 45 (< 3rd) 42 (< 3rd) 44 (< 3rd) 43 (< 3rd)
Birth head girth (cm)  30.0 (< 3rd) 31 (10th) 31.5 (10th) 31 (3rd) 32 (20th)
 (percentile)
Microcephaly  +   +   +   +   + 
Poor weight gain  +   +   +   +   + 
Corneal clouding or cataracts − −  + (with glaucoma)  +   + 
Microstomia  +   +   +   +   + 
High-arched palate  +   +   +   +   + 
Laryngomalacia  +   +   +   +   + 
Neonatal teeth −  +  −  +  −
Hypodontia/delayed dentition  +   +   +   +   + 
Microtia/dysplasia  +   +   +   +   + 
Hearing impairment  +   +   +   +   + 
Gastro-esophageal  +   +   +   +   + 
 reflux disease
Constipation   +   +   +   +  + Alternative
     chronic diarrhea
Organic aciduria  +   +   +   +   + 
Dermatitis/acrodermatitis  +  −  +  −  + 
 enteropathica
Seizure − − − −  + 
Hyperlipidemia − − − − −
Hypolipidemia  +   +   +   +   + 
Thyroid dysfunction  +   +   +   +  −
IGF-I decrease  +   +   +   +   + 
GH deficiency −  +  − −  + 
Delayed bone age  +   +   +   +   + 
Heart defect − − VSD − Atrial septal
     defect II + VSD
Inguinal hernia  +   +   +  −  + 
Cryptorchidism  +   −  +  
Camptodactyly  +   +   +   +   + 
Kyphoscoliosis  +   +   +  −  + 
Hip dysplasia − −  +   +   + 
Insulin resistance − − − − −
Fibroblast growth ND Slow Growth failure Slow Slow
Brain lesion noted by Ventriculo- Ventriculo- Ventriculo- Ventriculo-  Ventriculo-megaly, 
 echography/CT or MRI megaly megaly,  megaly,  megaly,  calcification, 
  delayed and then arachnoid delayed 
  myelination calcification cyst myelination
BMD (g/cm2) (age-year) 0.242 (1) 0.401 (6) 0.330 (4) 0.260 (1.4) 0.511 (8) to 
     0.528 (8.5y)
Z-score (SD) −2.1 −2.4 −2.2 −2.1 −2.0 to −1.7
Chromosome breakage test 46,XY;  46,XX;  46,XY;  46,XY;  46,XX; 
 increased increased increased normal increased
Mutations in LMNA, ERCC8, − − − − −
 and ZMPSTE24 genes
Outcome or age at present Died at Died at Died at Died at Alive, 
 1.1 years 6.2 years 4.2 years 1.5 years 8.5 years
 + = present; − = not present; CT = computed tomography; MRI = magnetic resonance imaging; BMD = bone mineral density; 
GH = growth hormone; IGF-I = insulin-like growth factor I; IUGR = intrauterine growth retardation; ND = not done; SD = standard 
deviation; VSD = ventricular septal defect.
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(thyroid stimulating hormone [TSH]; 13.5 mIU/L, 
2−10 mIU/L). Zinc gluconate and thyroxine were 
administered. He died of aspiration pneumonia and 
sepsis at 13 months old.
2.4. Patient 2
A female baby, born spontaneously via vagina and 
weighing 2350 g, length 45 cm, and HC 31 cm after 
a 36-week gestation, presented with a progeroid 
appearance (Figure 2) and history of elevated AFP 
with borderline IUGR.10 She had difficulty in swal-
lowing and required tube feeding for the first 2 
years after birth. Congenital stridor with laryngo-
malacia, neonatal teeth, moderate GER, seborrheic 
dermatitis, inguinal hernia, camptodactyly, which 
was resolved after the age of 2 years, and recurrent 
skin and respiratory tract infections were noted. 
However, slight scleroderma and mild photosensi-
tivity with reddish macules after sun exposure 
were also noted. She began to stand after 3 years 
and was unable to speak until after 4 years of age. 
Her immunoglobulin levels (IgG, IgA and IgM) were 
normal. Intravenous administration of pamidro-
nate (15 mg/m2/month) was given beginning at the 
age of 2 years because of osteoporosis and pro-
gressive scoliosis, with marked laxity of joints. Her 
BAER was impaired. GH deficiency was confirmed 
by very low IGF-I levels and regular insulin and clo-
nidine provocative tests. Borderline low levels of 
free T4 (12.2 pmol/L) and T3 (1.49 nmol/L) with 
normal TSH were noted. The patient died of aspi-
ration pneumonia at 6.2 years old.
2.5. Patient 3
This boy, born spontaneously via vagina and weigh-
ing 1750 g, length 42 cm, and HC 31.5 cm after a 
37-week gestation, had a history of elevated AFP, 
IUGR/SGA and postnatal growth retardation. Con-
genital glaucoma with corneal clouding, inguinal 
hernia, seborrheic and atopic dermatitis, hip dys-
plasia, camptodactyly and hypoplasia of the lower 
limb muscles were all found. An initial diagnosis of 
acrodermatitis enteropathica was made character-
ized by nail dysplasia and frequent loose stool pas-
sage. Low serum zinc and borderline low levels of 
free T4 (10.6 pmol/L) and T3 (1.49 nmol/L) with 
slightly elevated TSH (10.5 mIU/L) were noted. 
Contraction of his digits had been observed since 
birth and regressed spontaneously after early child-
hood (Figures 3A−C). Echocardiography showed a 
perimembranous ventricular septal defect (VSD). 
BAER was abnormal. Oral alendronate (5 mg/day, 
< 20 kg) was given to treat mild osteoporosis, pro-
gressive kyphoscoliosis and joint laxity. Scleroderma 
and photosensitivity were not found. Brain CT at 
4.1 years of age showed ventriculomegaly and basal 
ganglia calcification. The patient died of aspiration 
pneumonia and sepsis at 4.2 years old.
2.6. Patient 4
This male infant, born spontaneously via vagina 
and weighing 2100 g, length 44 cm, and HC 31 cm 
after a 39-week gestation, had history of polyhy-
dramnios with elevated AFP level, IUGR/SGA and 
neonatal teeth. Corneal clouding, laryngomalacia, 
cryptorchidism, camptodactyly and left hip dys-
plasia with dislocation were noted after birth. 
Severe neurosensory hearing impairment was de-
tected by BAER. Refractory GER with constipation 
persisted until the age of 1 year. The patient had 
marked growth retardation and hypotonia despite 
Figure 1 Patient 1 at the age of 9 months, showing a 
reversely triangular aged face, and contractural hand 
joints.
Figure 2 Patient 2 at the age of 8 months, with marked 
scalp veins.
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vigorous tube feeding. Thyroxine was given be-
cause of low levels of free T4 (8.6 pmol/L) and T3 
(0.81 nmol/L) with high TSH (25.1 mIU/L) were 
noted. He died of aspiration pneumonia and sepsis 
at 1.5 years old.
2.7. Patient 5
This female infant, born spontaneously via vagina and 
weighing 2150 g, length 43 cm, and HC 32 cm after 
a 36-week gestation, was the parents’ first child with 
IUGR/SGA. She had severe GER leading to profound 
growth retardation after birth. At an earlier age, 
she underwent insertion of a ventriculo-peritoneal 
shunt to treat suspected hydrocephalus. Serial ultra-
sonographs of the brain showed ventriculomegaly 
with brain atrophy. Constipation or chronic diarrhea, 
frequent infections, inguinal hernia, hypotonia, se-
borrheic dermatitis/coarse skin, and contractural 
arachnodactyly were noted. GH deficiency with very 
low IGF-I levels was also noted. Her thyroid func-
tion was normal. Echocardiography showed a type 
II atrial septal defect and a muscular-type VSD. The 
patient also had left hip dislocation, and progres-
sive scoliosis had developed since childhood. Oral 
alendronate was given because of osteoporosis with 
recurrent joint subluxation; her BMD improved with 
Z-scores changing from −2.0 to −1.7 after therapy 
for 6 months (Table). Seizure-like movements oc-
curred at the age of 3 years. The shunt was removed 
because of a tube infection at that time. An EEG 
showed diffuse cortical dysfunction and focal epi-
leptiform activity over the left centro-parietal area. 
Mild scleroderma persisted, but no signs of photo-
sensitivity were noted.
3. Results
All of the patients had a hydrocephaloid cranium 
with wide-open sutures and persistent AF, promi-
nent venous markings since birth, sparse scalp hair, 
frontal bossing, a small beaked nose, extensive 
adipose tissue deficiency, except for the cheeks, 
hands and feet (especially after the age of 3 years), 
and severely delayed growth in terms of body 
length and weight. Their pinched appearance was 
more easily assessed because of their low-set ears, 
deep-set eyes, scanty eyebrows and eyelashes, hy-
poplasia of the lower half of the face with small 
upper jaw and protruding chin, a reversely trian-
gular face with a senile appearance. The skin was 
thin, with abnormal pigmentation (hyperpigmenta-
tion but no acanthosis nigricans). The patients had 
relatively large hands and feet or fingers and toes, 
early loss of the neonatal teeth (Patients 1 and 3) 
and newly erupted dysplastic teeth, with dental 
maldevelopment. Small head circumference at birth 
was noted in two patients (Patients 1 and 4), but 
all of the patients developed microcephaly after 
4−12 months of age. They manifested borderline 
to marked pre- and postnatal growth retardation 
(Table). Retarded psychomotor development was 
observed in all five patients. Some neurologic signs 
such as ataxia, dysmetria, nystagmus, variable sever-
ity of mental retardation, and sensorineural hearing 
A
B
C
Figure 3 Patient 3, showing camptodactyly over both hands (A) and feet (B) at the age of 1 year, and resolution of 
joint contracture at the age of 4 years (C).
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impairment detected by BAER were also present. 
Although an accelerated aging phenotype was 
noted, their bone ages were delayed. Poor feeding 
and malnutrition were present in all patients. 
Episodes of hypoglycemia occurred after reduced 
food intake or diarrhea, and slight to mild iron de-
ficiency anemia was noted. All of the patients had 
decreased levels of serum albumin (2.4−2.9 g/dL, 
normal range: 2.8−5.4 g/dL), cholesterol (70−104 mg/
dL, 105−170 mg/dL), and triglyceride (25−40 mg/dL, 
30−100 mg/dL). However, urinalysis, globulin, classes 
of immunoglobulin, renal and liver function were 
all normal. Dermatitis, including seborrheic or at-
opic dermatitis, and acrodermatitis enteropathica 
occurred in every patient. Despite the provision of 
high-caloric nutrition, weight gain remained insuf-
ficient. EEGs showed diffuse cortical dysfunction 
in all patients. Ventriculomegaly, brain atrophy, de-
layed myelination, arachnoid cyst (Patient 4) and 
calcification (Patients 3 and 5) were detected by 
brain CT or MRI. In Patient 5, a brain CT done at the 
age of 3 years showed only ventriculomegaly, while 
at 6 years, multiple calcifications over bilateral basal 
ganglia and the white-gray matter junction of bi-
lateral frontal and parietal lobes appeared (Figures 
4A and B). All of the patients had slight to mild 
osteoporosis but no episodes of bone fracture.
3.1. Metabolic-endocrine study
Zinc deficiency (58.0−73.6 μg/dL, normal range 100−
120 μg/dL) was noted in each case. Low T3, free T4 
and/or high TSH levels were noted in Patients 1−4. 
Lactate/pyruvate, homocysteine, ammonia, corti-
sol and adrenocorticotropic hormone (ACTH) levels 
were all normal. Fasting plasma glucose, lipids 
and insulin levels were not elevated. No significant 
abnormalities were noted among markers of insulin 
resistance (Table). Delayed bone maturation and 
low IGF-I levels were found in all patients, but only 
Patients 2 and 5 had GH deficiency after GH pro-
vocative tests. Tandem mass spectrometry showed 
diffuse low levels of amino acids, free carnitine 
and fatty acids (except for high C4-DC carnitine in 
Patients 2, 3 and 5). Urine GC/MS showed diffuse 
organic aciduria in all patients: lactic acid (Patients 
1−5), dicarboxylic acid (Patients 1, 3 and 4), 3-
methylglutaconic acid (Patient 3), and 3-hydroxy-
3-methyl-glutaric acid (Patient 3).
3.2. Chromosome and DNA studies
High-resolution banding showed normal findings in 
every case. Breakage tests with mitomycin C (MMC) 
showed increased breakage rates in Patients 1 
(120% under MMC 40 ng/mL), 2 (157%), and 5 (144%) 
(control: 0.6−6.0%). Direct sequencing of all 12 
exons and splice sites of the LMNA gene, all 12 
exons of the ERCC8 gene, and all ten exons of the 
ZMPSTE24 gene using genomic DNA of all patients 
and their parents did not show any DNA abnormali-
ties or disease-causing variants.
4. Discussion
All patients presented with persistent aged and 
dysmorphic faces that were suggestive of NPS and 
which showed a different clinical course from other 
progeroid disorders such as congenital generalized 
lipodystrophy, Cockayne syndrome (CS),3 Hutchinson-
Gilford progeria syndrome (HGS),4 and Hallerman-
Streiff syndrome.11 HGS also has characteristics of 
premature aging, which, however, become apparent 
A B
Figure 4 Brain computed tomography scan of Patient 5 showing ventriculomegaly at the age of 3 years (A), and 
multiple calcification spots over bilateral basal ganglia and the white-gray matter junction of the frontal and parietal 
lobes at the age of 6 years (B).
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some time after birth, with accelerated aging and 
early death, frequently because of coronary artery 
disease. The premature aging process in NPS may 
or may not be related to other progeroid disorders. 
A progressive loss of telomeric DNA in cultured 
fibroblasts is a phenomenon in cellular senescence, 
with aging such as HGS progeria and mutations in 
LMNA having been reported in several other atypi-
cal progeroid syndromes.4,14 However, normal tel-
omere length has been noted in one patient of 
NPS,16 and mutations in LMNA and ZMPSTE24 genes 
were not observed in the present cases indicating 
that NPS does not involve laminopathy, as seen in 
classical progeria.
Abnormal findings of cytogenetic DNA repair 
studies in a patient with NPS have been reported.13 
Mosaic triploidy or tetraploidy were detected in 
60% and 14% of the fibroblast culture cells, respec-
tively.17 Chromosomal studies of peripheral leuko-
cytes in all patients and fibroblasts in three of our 
patients were karyotypically normal, while features 
indicative of defective DNA repair with markedly 
increased breakage rates were noted in four pa-
tients. In addition, the presence of calcification in 
the basal ganglia in Patients 3 and 5 implied over-
lapping features of CS.3 Further ERCC8 gene stud-
ies excluded the possibility of type A or II CS in all 
of these patients. Although the etiology of NPS re-
mains unknown, based on the laboratory findings 
and history of consanguinity, NPS may be an auto-
somal recessive condition associated with variable 
metabolic disturbances, DNA repair defects and 
premature aging.1,6−8,10,18
The findings in the present study and from 
Hagadorn et al,15 in which the detection of IUGR 
was delayed until 34−36 weeks of gestation, sug-
gest that IUGR in NPS occurs late during the third 
trimester, with a variable onset. Elevated maternal 
serum AFP levels at 16 weeks of gestation and late-
onset growth retardation appearing after 31 weeks 
were noted.15 AFP may serve as a useful biomarker 
for monitoring subsequent pregnancies to detect 
recurrence.
Various findings, including neonatal teeth/
abnormal dentition, delayed osseous maturation, 
osteoporosis and other skeletal abnormalities (arach-
nodactyly, camptodactyly), thin skin with hyperpig-
mentation, congenital hip dysplasia, and congenital 
heart defects are not uncommon in NPS. However, 
significant phenotypic variability exists among chil-
dren with NPS, although they all suffered from mild 
to moderate mental retardation. Elevated levels 
of T4 or normal thyroid function, endocrine metab-
olism related to insulin resistance, or increased 
serum triglyceride and very low density lipoprotein, 
as described in other reports,7,9,12 were not en-
countered in this study. Among our patients, relative 
hypolipidemia, hypothyroidism or hyperthyrotro-
pinemia were noted. Rare or hitherto unreported 
features, congenital or noted after infancy, such 
as corneal clouding, acrodermatitis enteropathica, 
thyroid dysfunction, GH deficiency, and organic aci-
duria were found, and which expand the clinical 
spectrum of NPS. The phenotypic variations also re-
veal genetic heterogeneity, probably due to muta-
tions in another gene(s).
Relatively large hands and feet with long fingers 
and toes/camptodactyly, which may resolve after 
infancy, were found, but progressive kyphoscoliosis-
associated osteopenia has been reported to develop 
when the patient grows older.20 It was shown that 
NPS cells showed a highly significant lower in vitro 
response to osteoblastic differentiation stimulus.19 
Furthermore, significantly fewer chondrocytes and 
hematopoietic cells were induced in NPS progeni-
tors compared with the control group.19 Kyphosco-
liosis usually developed as patients grew older.20 
Based on the findings of the present study, regular 
BMD monitoring and adequate therapy with bisphos-
phonate are helpful for NPS patients.
The neuropathologies of NPS patients were het-
erogeneous, including an almost complete absence 
of mature myelin or sudanophilic leukodystrophy 
in the brain,21 and abnormal to normal cerebral 
myelination.15,21 Ventriculomegaly with brain atro-
phy was common. Furthermore, the presence of 
calcification in the basal ganglia, cerebral white 
matter and cerebral cortex, which overlap with 
the features of CS,3 suggest that DNA repair de-
fects are involved in the pathogenesis of NPS.
Usually, NPS patients have short life expectancy 
due to malnutrition (leading to hypolipidemia and 
hypoalbuminemia) or after severe infection. Despite 
high-caloric nutrition, the weight gain is not suffi-
cient. The prognosis of NPS is also dependent on the 
presence and severity of mental and/or neurological 
impairment. The mental status in NPS patients ranges 
from normal (few patients) to mild-to-moderate 
mental retardation (very common).1,2,5,7−9,12,20 Life 
expectancy is about 7 months,7,8 although survival 
past the first decade has been reported, of up to 
15 years,8 16 years,2,20 and 17 years.9,12 With in-
creased age, the outward appearance remains un-
changed.2 Only one of these reports revealed the 
progeroid signs were no longer present at the age 
of 2 years 6 months, and the patient had a striking 
improvement in her psychomotor development.13 
Treatment is symptomatic. Because the curve of 
scoliosis progresses significantly with high rigidity, 
administration of pamidronate and surgical inter-
vention for correction and fusion is indicated.20 
Long-term follow-up is important to gain in-depth 
information about ultimate psychomotor develop-
ment and morbidities of such patients.
Neonatal progeroid syndrome 109
Osteoporosis and progressive scoliosis during 
childhood are common in NPS. Zinc deficiency, 
cerebral lesions, hypolipidemia, and GH deficits sug-
gest disturbed bone/nervous maturation, and lipid 
and GH metabolism may be etiologically important 
in NPS. A few reported NPS-like patients were con-
sidered as having an X-linked single-gene disorder 
or mitochondrial disorder; however, they had a 
strikingly different phenotype and did not meet 
the diagnostic criteria for NPS.12,22
In conclusion, NPS is clinically and genetically 
heterogeneous. Discovery of the gene and the met-
abolic pathway associated with this syndrome (with 
a relationship between the progeroid tendency and 
pathological myelination) will most likely enhance 
our understanding of the physiopathology of human 
aging.
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